News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Council Withdraws GlaxoSmithKline (GSK)'s Diabetes Medicine, Avandia



7/7/2011 7:00:39 AM

The Medicines Control Council has withdrawn the diabetes medicine Avandia from the market because it contains a substance that might increase the likelihood of a heart attack.The medication, produced by GlaxoSmithKline, is prescribed to some type2 diabetics.The council made the decision five weeks ago "due to safety risks" attributed to rosiglitazone, a constituent of Avandia. A statement by the council on Tuesday said: "Rosiglitazone is associated with an increased risk [of] heart failure, myocardial infarction [heart attack] and cardiac arrest".

Read at News Release
Read at News Release


comments powered by Disqus
   
Diabetes

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES